Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award!

Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award!

Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President of the American Methadone Treatment Association (now AATOD) and as Vice Chairman of the Governor’s Council on Alcohol and Drug Abuse in Maryland. Mr. Lane was a passionate advocate for methadone treatment (the only medication for opioid use disorder available at the time) and, by disclosing his own treatment experiences, provided inspiration to patients and colleagues alike.

Robert Holden was also a recovering heroin user, who later became the Director of PIDARC, an outpatient opioid treatment program in the District Of Columbia. He was a friend of Richard Lane and succeeded Richard Lane’s term of office as the Vice President of the American Association for the Treatment of Opioid Dependence (AATOD). This award was established in 1995 and recognizes extraordinary achievements in medication assisted treatment (MAT) patient advocacy.

The following criteria should be applied in making your selection:

  • Only one (1) nominee can be submitted by NAMA Recovery to the Conference Awards Committee. There may be a number of nominees however only one (1) “consensus” nominee may receive this honor.
  • The nominee must have been involved in the field of Medication Assisted Treatment (MAT) advocacy for a period of five (5) years.
  • The nominee must have made meaningful and consistent contributions, which have had a significant impact on opioid treatment within a state or region of the United States.
  • For each nominee a Nomination Form must be completed and submitted with two (2) Letters of Support.

NAMA Recovery will be responsible for collecting all the submissions for nomination and selecting a committee of advocates that will decide on the final candidate. The Candidate’s Name, Nomination Form and at least two (2) Letters of Support describing the nominee’s achievements will be submitted to the AATOD Conference Awards Committee for the final approval.

The deadline for submissions is Friday June 24, 2022, at 5:00pm Eastern Daylight Time.

The Nomination Form should be completed online HERE.

Two (2) or more Letters of Support should be sent via email to [email protected]

Previous Winners of the Award:

Richard Lane, 1995, Arizona
Joycelyn Woods, 2001, St. Louis
Anthony Scro, 2007, San Diego
Walter Ginter, 2009, New York
Lisa Mojer Torres, 2010, Chicago
Roxanne Baker, 2012, Las Vegas
Ira Marion, 2013, Philadelphia
Claude Hopkins, 2015, Atlanta
Brenda Davis, 2016, Baltimore
Paul Bowman, 2017 New York
Zachary Talbott, 2019 Orlando
Jana Burson, 2021 Las Vegas

This Award will be bestowed upon the recipient during the Awards Banquet Ceremony during the National AATOD Conference which will convene in Baltimore, Maryland in October.
The recipient will be provided with a roundtrip Coach Class airfare, up to two (2) nights in the hotel and Conference Registration.

Similar Posts

  • AMTA Conference Comittee

    Admin 06/15/2023

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Committee Members Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager:…

  • Tag: Herman Joseph

    Admin 11/13/2022

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • Myths About Methadone by Emmett Velten-2

    Admin 10/11/2022

    Not just in substance abuse, mental health, and AIDS services do methadone patients face routine discrimination.  San Francisco MUNI will not allow methadone patients to drive its buses, even though an important legal ruling in New York overturned a similar policy (Beazer vs New York City Transit Authority, 1975). Not just in those instances but…

  • Stop Methadone Ignorance

    Admin 08/26/2022

    Six Steps to Zero Deaths Never take a prescription painkiller unless it is prescribed to you. Everyone responds differently to pain medications. What is safe for one person may not be safe for another. Do not take pain medicine with alcohol. Never mix the two, it is a dangerous combination that can be deadly. Alcohol…

  • Focus On

    Admin 09/16/2021

    Issues To Focus On LAAM Manufacture to Be Discontinued August 23, 2003 Washington, D.C. Roxanne the manufacturer of LAAM has informed the FDA that manufacture of the medication is being discontinued. Distribution will continue until the inventory is depleted. Roxanne estimates this to be in early January 2004. The reason for the action is the…

  • NAMA Talk

    Admin 02/07/2022

    Volumn 2, Number 1 February 15, 2000 Organizational News by Joycelyn Woods The big news as this year and the Millennium closes is that methadone is slowly moving to being an accepted medical treatment. This is only the beginning THE FIRST STEP – and there is still an immense amount of work to be done….